OMRON Healthcare Highlights Key Heart Health Issues at ESC Congress 2025
OMRON Healthcare Co., Ltd., renowned for being the most recommended blood pressure monitor brand globally by healthcare professionals, is gearing up to participate in the prestigious ESC Congress 2025. This significant event, organized by the European Society of Cardiology, promises to bring together medical experts and health tech innovators to explore the latest research and advancements in cardiology.
Addressing Undiagnosed Heart Failure in Women
This year's congress will feature OMRON Healthcare sponsoring an important symposium entitled "Unveiling the hidden threat: recognising undiagnosed heart failure in women." This session will take place at IFEMA Madrid and aims to shed light on the often-overlooked cardiovascular health issues faced by women. Recent statistics reveal a troubling pattern; despite being the leading cause of death among women, cardiovascular disease remains frequently underdiagnosed and undertreated.
The Importance of Awareness
A fascinating study conducted by OMRON Healthcare found that many women experience early warning signs of heart disease, such as palpitations and shortness of breath, yet fail to seek medical advice, often attributing their symptoms to menopause. This alarming trend highlights the need for increased awareness and better understanding of cardiovascular issues that predominantly affect women.
The Role of Technology in Cardiac Care
OMRON Healthcare advocates for the use of their innovative self-measurement tools, which play a crucial role in early diagnosis. The company is set to introduce a new series of upper-arm blood pressure monitors equipped with an AI-powered algorithm that will assist in identifying symptoms of atrial fibrillation. The monitors will sync with the OMRON connect app, enabling users to track patterns and share vital health data with healthcare professionals.
Leading Experts Supporting the Initiative
Joining OMRON Healthcare's initiative are notable experts such as Alta Schutte from the George Institute for Global Health in Australia, Eva Gerdts from the University of Bergen in Norway, and Renate B. Schnabel from the University Heart and Vascular Centre Hamburg in Germany. They will lead presentations focusing on understanding the risks associated with female heart failure and the importance of early detection.
OMRON Healthcare's Commitment to Global Heart Health
This participation at ESC Congress 2025 underlines OMRON Healthcare's ongoing commitment to enhancing cardiovascular care globally. The company's Managing Director for Europe, Karen Benegmos-Sanders, expressed enthusiasm about returning to the congress, emphasizing the importance of bringing experts together to discuss pressing issues in cardiovascular care and the responsibility of promoting at-home monitoring.
Connecting Innovative Solutions with Consumer Needs
As part of their commitment, OMRON Healthcare will offer attendees at the congress a first look at their new BPM series. This initiative aims to revolutionize heart-health outcomes around the world by promoting early detection and continuous monitoring.
Frequently Asked Questions
What is the main focus of OMRON Healthcare at ESC Congress 2025?
OMRON Healthcare aims to address the serious issue of undiagnosed heart failure in women, emphasizing the importance of awareness and early detection.
Who are the leading experts participating in the symposium?
Experts include Alta Schutte, Eva Gerdts, and Renate B. Schnabel, who will present on crucial aspects of women's heart health.
What innovative technology is OMRON showcasing?
OMRON is presenting a new series of upper-arm blood pressure monitors featuring AI technology to assist in detecting atrial fibrillation.
Why is cardiovascular disease particularly concerning for women?
Research indicates that cardiovascular disease is often underdiagnosed and undertreated in women, leading to significant health risks.
How can OMRON's technology help in heart health management?
The technology allows for self-measurement and data sharing with healthcare professionals, enhancing early detection and management of heart-related conditions.
